We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Cardiology

Journal Scan / Research · April 13, 2021

Similar Outcomes With the CD34 Antibody–Covered Sirolimus-Eluting Combo Stent and Sirolimus-Eluting Orsiro Stent



Additional Info

Disclosure statements are available on the authors' profiles:

Randomized Clinical Comparison of the Dual Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention: The SORT OUT X Trial
Circulation 2021 Apr 07;[EPub Ahead of Print], L Jakobsen, EH Christiansen, P Freeman, J Kahlert, K Veien, M Maeng, B Raungaard, J Ellert, AB Villadsen, SD Kristensen, O Ahlehoff, MK Christensen, CJ Terkelsen, HE Bøtker, J Aaroe, T Thim, L Thuesen, A Aziz, A Eftekhari, RV Jensen, NB Støttrup, JG Rasmussen, A Junker, SE Jensen, HS Hansen, LO Jensen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading